MINNEAPOLIS, January 23 /PRNewswire/ --

- Designed for SMS Applications in SMB Business Environments

MARRAKECH, Morocco, January 23 /PRNewswire/ --

- New Environmental Initiative Coincides with European Union's First Commitment Period of the Kyoto Protocol;

- Atlas-Blue and Airsavings Develop Program To Eliminate Carbon Footprint Created By Air Travel

LONDON, January 23 /PRNewswire/ --

- Call for Applications 2008

The Cartier Women's Initiative Awards is a unique and international business plan competition for female entrepreneurs with creative, sustainable and socially responsible businesses in the initial phase.

Created in 2006 by Cartier and the Women's Forum with the support of McKinsey and INSEAD management school, it offers the chance to win personalised coaching support for a full year, a US$20 000 grant, numerous networking and visibility opportunities.

Log on to http://www.cartierwomensinitiative.com to find out more or contact the Cartier UK Press Office, Sarah Carlsen, on +44-(0)20-7408-5740 or sarah.carlsen@cartier.com

About the Partnership

TEMPE, Arizona, January 23 /PRNewswire/ --

Circuit Research Labs, Inc. (OTC Bulletin Board: CRLI), parent company of Orban/CRL, a worldwide leader in audio processing for AM, FM, TV, and Internet broadcasting today announced major changes to its European operations.

With a new central processing center for Europe effective February 15, 2008, Orban Europe will now be fully responsible for all sales, orders, repairs and accounting in the European Union. Additionally, the company will begin full production and manufacturing of all Orban products in Germany later this year.

I was puttering around the attic of the Cashominium, trying to sort through some old boxes, and I came across something you all might find interesting. Before any of this makes sense, I need to give you a little family background.

Like many, the Cash family has been here a long time (a long time for America, anyway - here a hundred years is a long time and in Europe a hundred miles is a long distance, so it's all perspective) but we are not blueblooded fancy-pants Mayflower descendants or anything like that. We arrived just over 160 years ago.

LONDON, January 23 /PRNewswire/ --

FocusVision, the world's leading provider of video transmission, recording and analytical tools for market research, today announced the expansion of their lower-priced fixed-camera "VideoStreaming" solution in Europe. With this offering, FocusVision is able to deliver a choice of service at a lower price point, while reaffirming its commitment to providing clients with the industry's most reliable video transmission services.

EDINBURGH, Scotland, January 23 /PRNewswire/ --

- Aircraft Medical's Success at European Patent Hearing is Confirmed by Verathon's Appeal.

The European Patent Office (EPO) has found Verathon's European Patent (the '131' patent) not valid as granted. In a ruling on Oct 16, 2007, a narrower version of the patent was upheld. In a PR twist however, Verathon issued a press statement into wide distribution announcing the EPO ruling as a success, despite the fact that the ruling severely weakened its patent.

Verathon has now appealed the EPO's October 2007 ruling. This appeal very effectively demonstrates that the EPO decision was in fact not favourable to Verathon.

The price of oil topped $100 on January 2 and again on January 3. During the days since I have received emails and phone calls from regular readers, complimenting me on my correct prediction.
http://www.sciencedaily.com/releases/2008/01/080109173722.htm

The above address is a post on Science Daily about an antimatter cloud. This should be of interest to the hard core science types and SiFi fans like myself.

The post describes an antimatter cloud that surrounds the galactic center. This cloud is about 10,000 light-years across. The European Space Agency’s "Integral" satellite has provided clues to the possible origin of this antimatter cloud. This post is well worth reading.

TARRYTOWN, New York, January 23 /PRNewswire/ --

EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today provided updates on the regulatory and clinical status of Ceplene(TM) (histamine dihydrochloride) and EpiCept(TM) NP-1 Cream.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

EpiCept announced today that its Marketing Authorization Application (MAA) seeking marketing approval for Ceplene in the European Union has advanced to the next important step. The Company has submitted full written responses to the Day 180 List of Outstanding Issues to the Committee for Human Medicinal Products (CHMP). With this response, EpiCept believes it has now addressed all outstanding issues related to the MAA.